newsfilter
← Latest News
GlobeNewswire·

BioVaxys Technology Corp. to Present at the Life Sciences Investor Forum September 19th 2024

VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of